IUBio

AIDS DRUGS COULD LEAD TO MORE INFECTIONS

Jaime Finguerut JAIME.CTTI-3.CTTI.CTC at azul.ctc.com.br
Wed Jan 27 05:41:57 EST 1999


               *********************************************
              *                                           *
              *                News Direct                *
              *                                           *
              *********************************************


Wednesday, Twenty-Seventh January 1999
                              ---------

     AIDS DRUGS COULD LEAD TO MORE INFECTIONS Powerful new drug
     combination therapies designed to to treat AIDS could
     backfire, according to US infectious disease experts. Up to
     20% more people may become infected with the disease as a
     result of the HIV virus developing resistance to the
     drugs. Sally Blower, a microbiologist at the University of
     California, has developed a mathematical model to forecast the
     increase of drug-resistant strains of HIV in San Francisco.
     The model shows that if all patients received the optimal
     treatment of combination protease inhibitors then infections
     would go down by 20%. But patients rarely get optimal
     treatment, she says. They often fail to comply with
     complicated drug regimes, doctors often prescribe
     inappropriate or incorrect doses and some patients are simply
     incompatible with the drugs.  Any failure in the treatment
     process gives the virus a chance to mutate and develop
     resistance. If the resistant form of the virus is transmitted
     new infections could be impossible to treat, she says. The
     model predicts that the spread of resistant strains could
     eventually lead to a 20% increase in new HIV infections after
     10 years. 'This type of transmission has already occurred,'
     said David Baltimore, an AIDS vaccine specialist who is
     president of the California Institute of Technology.   The
     model suggests that the number of new infections will depend
     on how successful patients are at keeping to the strict
     combination therapy regimes, Blower said. She stressed,
     however, that the answer is not to withhold treatment but to
     emphasise compliance and to encourage patients to eschew risky
     sexual practices. Blower presented her findings to an American
     Association for the Advancement of Science meeting in Anaheim,
     California on Saturday 23 January.

                               ---------

------------------------------------
Jaime Finguerut (Mr., chem.eng.)
Copersucar
Cx.Postal 162 Piracicaba
Sao Paulo BRAZIL 13400-970
fax +55 19 429 8109
jaime at azul.ctc.com.br



More information about the Microbio mailing list

Send comments to us at biosci-help [At] net.bio.net